{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T11:47:50Z","timestamp":1780487270147,"version":"3.54.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T00:00:00Z","timestamp":1643760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T00:00:00Z","timestamp":1643760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Calgary Health Trust"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Heart failure (HF) admission is a dominant contributor to morbidity and healthcare costs in dilated cardiomyopathy (DCM). Mid-wall striae (MWS) fibrosis by late gadolinium enhancement (LGE) imaging has been associated with elevated arrhythmia risk. However, its capacity to predict HF-specific outcomes is poorly defined. We investigated its role to predict HF admission and relevant secondary outcomes in a large cohort of DCM patients. 719 patients referred for LGE MRI assessment of DCM were enrolled and followed for clinical events. Standardized image analyses and interpretations were conducted inclusive of coding the presence and patterns of fibrosis observed by LGE imaging. The primary clinical outcome was hospital admission for decompensated HF. Secondary heart failure and arrhythmic composite endpoints were also studied. Median age was 57 (IQR 47\u201365) years and median LVEF 40% (IQR 29\u201347%). Any fibrosis was observed in 228 patients (32%) with MWS fibrosis pattern present in 178 (25%). At a median follow up of 1044\u00a0days, 104 (15%) patients experienced the primary outcome, and 127 (18%) the secondary outcome. MWS was associated with a 2.14-fold risk of the primary outcome, 2.15-fold risk of the secondary HF outcome, and 2.23-fold risk of the secondary arrhythmic outcome. Multivariable analysis adjusting for all relevant covariates, inclusive of LVEF, showed patients with MWS fibrosis to experience a 1.65-fold increased risk (95% CI 1.11\u20132.47) of HF admission and 1-year event rate of 12% versus 7% without this phenotypic marker. Similar findings were observed for the secondary outcomes. Patients with LVEF\u2009&gt;\u200935% plus MWS fibrosis experienced similar event rates to those with LVEF\u2009\u2264\u200935%. MWS fibrosis is a powerful and independent predictor of clinical outcomes in patients with DCM, identifying patients with LVEF\u2009&gt;\u200935% who experience similar event rates to those with LVEF below this conventionally employed high-risk phenotype threshold.<\/jats:p>","DOI":"10.1038\/s41598-022-05790-y","type":"journal-article","created":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T06:06:03Z","timestamp":1643781963000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Mid-wall striae fibrosis predicts heart failure admission, composite heart failure events, and life-threatening arrhythmias in dilated cardiomyopathy"],"prefix":"10.1038","volume":"12","author":[{"given":"Yanish","family":"Purmah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aidan","family":"Cornhill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy Y.","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Dykstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Mikami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Satriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Labib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Flewitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Rivest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Sandonato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Seib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew G.","family":"Howarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen P.","family":"Lydell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobak","family":"Heydari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naeem","family":"Merchant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bristow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Kolman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nowell M.","family":"Fine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,2]]},"reference":[{"issue":"9","key":"5790_CR1","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1136\/hrt.2003.025270","volume":"93","author":"A Mosterd","year":"2007","unstructured":"Mosterd, A. & Hoes, A. W. Clinical epidemiology of heart failure. Heart [Internet] 93(9), 1137\u20131146 (2007).","journal-title":"Heart [Internet]"},{"issue":"2","key":"5790_CR2","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","volume":"29","author":"P Elliott","year":"2008","unstructured":"Elliott, P. et al. Classification of the cardiomyopathies: A position statement from the European society of cardiology working group on myocardial and pericardial diseases. Eur Heart J 29(2), 270\u2013276 (2008).","journal-title":"Eur Heart J"},{"issue":"2","key":"5790_CR3","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ijcard.2010.01.011","volume":"149","author":"R Pecini","year":"2011","unstructured":"Pecini, R., M\u00f8ller, D. V., Torp-Pedersen, C., Hassager, C. & K\u00f8ber, L. Heart failure etiology impacts survival of patients with heart failure. Int J Cardiol [Internet] 149(2), 211\u2013215 (2011).","journal-title":"Int J Cardiol [Internet]"},{"issue":"6","key":"5790_CR4","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.jchf.2019.02.015","volume":"7","author":"C Balmforth","year":"2019","unstructured":"Balmforth, C. et al. Outcomes and effect of treatment according to etiology in HFrEF. JACC Hear Fail 7(6), 457\u2013465 (2019).","journal-title":"JACC Hear Fail"},{"issue":"27","key":"5790_CR5","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski, P. et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 37(27), 2129\u20132200. https:\/\/doi.org\/10.1093\/eurheartj\/ehw128 (2016).","journal-title":"Eur Heart J"},{"issue":"9","key":"5790_CR6","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1001\/jama.2013.1363","volume":"309","author":"A Gulati","year":"2013","unstructured":"Gulati, A. et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA J Am Med Assoc 309(9), 896\u2013908 (2013).","journal-title":"JAMA J Am Med Assoc"},{"issue":"10","key":"5790_CR7","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1016\/j.jacc.2006.07.049","volume":"48","author":"RG Assomull","year":"2006","unstructured":"Assomull, R. G. et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 48(10), 1977\u20131985 (2006).","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"5790_CR8","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1136\/hrt.2010.205542","volume":"97","author":"S Lehrke","year":"2011","unstructured":"Lehrke, S. et al. Use of cardiovascular magnetic resonance for risk stratification in chronic heart failure: Prognostic value of late gadolinium enhancement in patients with non-ischaemic dilated cardiomyopathy. Heart 97(9), 727\u2013732 (2011).","journal-title":"Heart"},{"issue":"9","key":"5790_CR9","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.jcmg.2013.05.013","volume":"6","author":"TG Neilan","year":"2013","unstructured":"Neilan, T. G. et al. CMR quantification of myocardial scar provides additive prognostic information in nonischemic cardiomyopathy. JACC Cardiovasc Imaging 6(9), 944\u2013954 (2013).","journal-title":"JACC Cardiovasc Imaging"},{"issue":"17","key":"5790_CR10","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1016\/j.jacc.2012.05.054","volume":"60","author":"F Leyva","year":"2012","unstructured":"Leyva, F. et al. Left ventricular midwall fibrosis as a predictor of mortality and morbidity after cardiac resynchronization therapy in patients with nonischemic cardiomyopathy. J Am Coll Cardiol 60(17), 1659\u20131667. https:\/\/doi.org\/10.1016\/j.jacc.2012.05.054 (2012).","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"5790_CR11","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.jacc.2010.06.062","volume":"57","author":"L Iles","year":"2011","unstructured":"Iles, L. et al. Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. J. Am. Coll. Cardiol. 57(7), 821\u2013828. https:\/\/doi.org\/10.1016\/j.jacc.2010.06.062 (2011).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"25","key":"5790_CR12","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1016\/j.jacc.2008.03.018","volume":"51","author":"KC Wu","year":"2008","unstructured":"Wu, K. C. et al. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J. Am. Coll. Cardiol. 51(25), 2414\u20132421 (2008).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"5790_CR13","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1161\/01.CIR.0000078641.19365.4C","volume":"108","author":"JA McCrohon","year":"2003","unstructured":"McCrohon, J. A. et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 108(1), 54\u201359. https:\/\/doi.org\/10.1161\/01.CIR.0000078641.19365.4C (2003).","journal-title":"Circulation"},{"issue":"8P2","key":"5790_CR14","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1016\/j.jcmg.2018.07.015","volume":"12","author":"BP Halliday","year":"2019","unstructured":"Halliday, B. P. et al. Outcome in dilated cardiomyopathy related to the extent, location, and pattern of late gadolinium enhancement. JACC Cardiovasc. Imaging 12(8P2), 1645\u20131655 (2019).","journal-title":"JACC Cardiovasc. Imaging"},{"issue":"22","key":"5790_CR15","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1161\/CIRCULATIONAHA.116.026910","volume":"135","author":"BP Halliday","year":"2017","unstructured":"Halliday, B. P. et al. Association between midwall late gadolinium enhancement and sudden cardiac death in patients with dilated cardiomyopathy and mild and moderate left ventricular systolic dysfunction. Circulation 135(22), 2106\u20132115 (2017).","journal-title":"Circulation"},{"issue":"11","key":"5790_CR16","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1111\/jce.12767","volume":"26","author":"M Chimura","year":"2015","unstructured":"Chimura, M. et al. Distribution of ventricular fibrosis associated with life-threatening ventricular tachyarrhythmias in patients with nonischemic dilated cardiomyopathy. J. Cardiovasc. Electrophysiol. 26(11), 1239\u20131246 (2015).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"5790_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/CIRCIMAGING.119.010105","volume":"13","author":"AC Alba","year":"2020","unstructured":"Alba, A. C. et al. Prognostic value of late gadolinium enhancement for the prediction of cardiovascular outcomes in dilated cardiomyopathy: An international, multi-institutional study of the MINICOR group. Circ. Cardiovasc. Imaging 13, 1\u201312 (2020).","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"5790_CR18","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1161\/CIRCIMAGING.120.011337","volume":"14","author":"Y Purmah","year":"2021","unstructured":"Purmah, Y. et al. Right ventricular ejection fraction for the prediction of major adverse cardiovascular and heart failure-related events: A cardiac MRI based study of 7131 patients with known or suspected cardiovascular disease. Circ. Cardiovasc. Imaging 14, 224\u2013235 (2021).","journal-title":"Circ. Cardiovasc. Imaging"},{"issue":"1","key":"5790_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1532-429X-15-35","volume":"15","author":"J Schulz-Menger","year":"2013","unstructured":"Schulz-Menger, J. et al. Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) Board of Trustees Task Force on Standardized Post Processing. J. Cardiovasc. Magn. Reson. 15(1), 35. https:\/\/doi.org\/10.1186\/1532-429X-15-35 (2013).","journal-title":"J. Cardiovasc. Magn. Reson."},{"issue":"4","key":"5790_CR20","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1161\/CIRCIMAGING.113.001768","volume":"7","author":"F Almehmadi","year":"2014","unstructured":"Almehmadi, F. et al. Prevalence of myocardial fibrosis patterns in patients with systolic dysfunction. Circ. Cardiovasc. Imaging 7(4), 593\u2013600. https:\/\/doi.org\/10.1161\/CIRCIMAGING.113.001768 (2014).","journal-title":"Circ. Cardiovasc. Imaging"},{"issue":"6","key":"5790_CR21","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1002\/jmri.24116","volume":"38","author":"NM Fine","year":"2013","unstructured":"Fine, N. M. et al. Validation of sub-segmental visual scoring for the quantification of ischemic and nonischemic myocardial fibrosis using late gadolinium enhancement MRI. J. Magn. Reson. Imaging 38(6), 1369\u20131376 (2013).","journal-title":"J. Magn. Reson. Imaging"},{"issue":"6","key":"5790_CR22","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1161\/CIRCULATIONAHA.115.017719","volume":"133","author":"PC Austin","year":"2016","unstructured":"Austin, P. C., Lee, D. S. & Fine, J. P. Introduction to the analysis of survival data in the presence of competing risks. Circulation 133(6), 601\u2013609 (2016).","journal-title":"Circulation"},{"issue":"7","key":"5790_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/CIRCOUTCOMES.118.004580","volume":"11","author":"H Abdel-Qadir","year":"2018","unstructured":"Abdel-Qadir, H. et al. Importance of considering competing risks in time-to-event analyses: Application to stroke risk in a retrospective cohort study of elderly patients with atrial fibrillation. Circ. Cardiovasc. Qual. Outcomes 11(7), 1\u201311 (2018).","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"issue":"6","key":"5790_CR24","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.jacc.2020.11.022","volume":"77","author":"TM Maddox","year":"2021","unstructured":"Maddox, T. M. et al. 2021 update to the 2017 ACC expert consensus decision pathway for optimization of heart failure treatment: answers to 10 pivotal issues about heart failure with reduced ejection fraction: A report of the American college of cardiology solution set oversig. J. Am. Coll. Cardiol. 77(6), 772\u2013810 (2021).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"5790_CR25","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.cjca.2021.01.017","volume":"37","author":"M McDonald","year":"2021","unstructured":"McDonald, M. et al. CCS\/CHFS heart failure guidelines update: Defining a new pharmacologic standard of care for heart failure with reduced ejection fraction. Can. J. Cardiol. 37(4), 531\u2013546. https:\/\/doi.org\/10.1016\/j.cjca.2021.01.017 (2021).","journal-title":"Can. J. Cardiol."},{"issue":"29","key":"5790_CR26","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1093\/eurheartj\/eht150","volume":"34","author":"M Brignole","year":"2013","unstructured":"Brignole, M. et al. 213 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur. Heart J. 34(29), 2281\u20132329 (2013).","journal-title":"Eur. Heart J."},{"key":"5790_CR27","first-page":"382","volume":"2019","author":"FM Kusumoto","year":"2018","unstructured":"Kusumoto, F. M. et al. ACC\/AHA\/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhyth. Vol. 140. Circulation 2019, 382\u2013482 (2018).","journal-title":"Circulation"},{"issue":"3","key":"5790_CR28","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1253\/circj.CJ-09-0446","volume":"74","author":"JR Cho","year":"2010","unstructured":"Cho, J. R. et al. Delayed enhancement magnetic resonance imaging is a significant prognostic factor in patients with non-ischemic cardiomyopathy. Circ. J. 74(3), 476\u2013483 (2010).","journal-title":"Circ. J."},{"issue":"9","key":"5790_CR29","doi-asserted-by":"publisher","first-page":"e007722","DOI":"10.1161\/CIRCIMAGING.118.007722","volume":"11","author":"A Gulati","year":"2018","unstructured":"Gulati, A. et al. Absence of myocardial fibrosis predicts favorable long-term survival in new-onset heart failure. Circ. Cardiovasc. Imaging 11(9), e007722 (2018).","journal-title":"Circ. Cardiovasc. Imaging"},{"issue":"9","key":"5790_CR30","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/j.jcmg.2018.03.006","volume":"11","author":"MAJ Becker","year":"2018","unstructured":"Becker, M. A. J. et al. The prognostic value of late gadolinium-enhanced cardiac magnetic resonance imaging in nonischemic dilated cardiomyopathy: A review and meta-analysis. JACC Cardiovasc. Imaging 11(9), 1274\u20131284 (2018).","journal-title":"JACC Cardiovasc. Imaging"},{"issue":"2","key":"5790_CR31","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1161\/CIRCIMAGING.113.001144","volume":"7","author":"S Kuruvilla","year":"2014","unstructured":"Kuruvilla, S. et al. Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: A systematic review and meta-analysis. Circ. Cardiovasc. Imaging 7(2), 250\u2013257 (2014).","journal-title":"Circ. Cardiovasc. Imaging"},{"issue":"9","key":"5790_CR32","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.jcmg.2016.01.033","volume":"9","author":"M Disertori","year":"2016","unstructured":"Disertori, M. et al. Myocardial fibrosis assessment by LGE is a powerful predictor of ventricular tachyarrhythmias in ischemic and nonischemic LV dysfunction: A meta-analysis. JACC Cardiovasc. Imaging 9(9), 1046\u20131055 (2016).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"5790_CR33","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ijcard.2017.10.094","volume":"254","author":"AN Ganesan","year":"2018","unstructured":"Ganesan, A. N., Gunton, J., Nucifora, G., McGavigan, A. D. & Selvanayagam, J. B. Impact of late gadolinium enhancement on mortality, sudden death and major adverse cardiovascular events in ischemic and nonischemic cardiomyopathy: A systematic review and meta-analysis. Int. J. Cardiol. 254, 230\u2013237. https:\/\/doi.org\/10.1016\/j.ijcard.2017.10.094 (2018).","journal-title":"Int. J. Cardiol."},{"issue":"1","key":"5790_CR34","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jchf.2016.09.017","volume":"5","author":"A Di Marco","year":"2017","unstructured":"Di Marco, A. et al. Late gadolinium enhancement and the risk for ventricular arrhythmias or sudden death in dilated cardiomyopathy: systematic review and meta-analysis. JACC Heart Fail. 5(1), 28\u201338 (2017).","journal-title":"JACC Heart Fail."},{"key":"5790_CR35","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2147\/RMHP.S130341","volume":"10","author":"M Kilgore","year":"2017","unstructured":"Kilgore, M., Patel, H., Kielhorn, A., Maya, J. & Sharma, P. Economic burden of hospitalizations of Medicare beneficiaries with heart failure. Risk Manag. Healthc. Policy 10, 63\u201370 (2017).","journal-title":"Risk Manag. Healthc. Policy"},{"issue":"6","key":"5790_CR36","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1136\/heart.89.6.615","volume":"89","author":"HM Blackledge","year":"2003","unstructured":"Blackledge, H. M., Tomlinson, J. & Squire, I. B. Prognosis for patients newly admitted to hospital with heart failure: Survival trends in 12 220 index admissions in Leicestershire 1993\u20132001. Heart 89(6), 615\u2013620 (2003).","journal-title":"Heart"},{"issue":"5","key":"5790_CR37","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1001\/archinte.167.5.490","volume":"167","author":"RJ Goldberg","year":"2007","unstructured":"Goldberg, R. J. Long-term survival after heart failure. Arch. Intern. Med. 167(5), 490. https:\/\/doi.org\/10.1001\/archinte.167.5.490 (2007).","journal-title":"Arch. Intern. Med."},{"issue":"4","key":"5790_CR38","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1161\/CIRCULATIONAHA.108.812172","volume":"119","author":"PS Jhund","year":"2009","unstructured":"Jhund, P. S. et al. Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003. Circulation 119(4), 515\u2013523. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.812172 (2009).","journal-title":"Circulation"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05790-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05790-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05790-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T16:36:36Z","timestamp":1669307796000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05790-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,2]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["5790"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-05790-y","relation":{"has-review":[{"id-type":"doi","id":"10.32388\/EX17DI","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,2]]},"assertion":[{"value":"31 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr James White is a shareholder of Cohesic Inc and has received research funding from Siemens Healthineers. The remaining authors have nothing to disclose<b>.<\/b>","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1739"}}